Evidence map›Paper›PMID 40067465›Full record

ReviewSeminars in immunopathology2025

The when, what, and where of naturally-acquired microchimerism.

J Lee Nelson, Nathalie C Lambert

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Fetal-Onset Autoimmune Hemolytic Anemia and Thrombocytopenia Followed by Giant Cell Hepatitis: A Case Report.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Article
  4. Review
  5. Micro-chimerism: from evolution to revolution.Seminars in immunopathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J Lee NelsonDepartment of Medicine, University of Washington, Seattle, WA, USA. lee@fredhutch.org.ORCID http://orcid.org/0000-0003-3163-1940
Nathalie C LambertINSERM UMRs 1097 Arthrites, Microchimérisme et Inflammations (ARTHEMIS), Aix Marseille Université, Marseille, France. nathalie.lambert@inserm.fr.

Funding

ALLOIMMUNITY IN AUTO IMMUNE DISEASER01AI045659 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, J. LEE · 1999 to 2009
$3.4M
Microchimerism as AlloImmunityR01HL117737 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NELSON, J. LEE · 2014 to 2018
$2.4M
The Brain and Maternal MicrochimerismR21NS118249 · NINDS · UNIVERSITY OF WASHINGTON · PI NELSON, J. LEE, WEINSTEIN, JONATHAN R · 2021 to 2021
$473k
HLA at the Interface of Self and Other During PregnancyR03AI159288 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KANAAN, SAMI BARNA, NELSON, J. LEE · 2021 to 2022
$176k
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases 45659NHLBI NIH HHS 117737NHLBI NIH HHS R01 HL117737NIAID NIH HHS R01 AI045659NIAID NIH HHS R03 AI159288NINDS NIH HHS R21 NS118249
6 · The paper itself

Abstract

Naturally acquired microchimerism (Mc) is increasingly recognized as an aspect of normal biology. Maternal-fetal bi-directional exchange during pregnancy creates a Mc legacy for the long-term in both individuals. Maternal Mc in her offspring and Mc of fetal origin in women with previous births are best studied. Other sources include from a known or vanished twin, miscarriage or pregnancy termination, older sibling, or previous maternal pregnancy loss. Mc is pleotropic and protean, present in diverse forms, and changing over time as other aspects of biology. Mc acquired from multiple sources, at different lifespan times, and taking on an array of diverse forms, creates a "forward, reverse, and horizontal inheritance" Mc landscape. Mc is found in adaptive and innate immune cells, as resident tissue-specific cells in a wide variety of human tissues, and among other forms as extracellular vesicles. HLA molecules function in a myriad of ways as key determinants for health and are of central importance in interactions between genetically disparate individuals. Studies of autoimmune disease have firmly established a primary role of HLA molecules. Studies of iatrogenic chimerism have established benefit of donor-recipient HLA-disparity against recurrent malignancy after transplantation. HLA molecules and HLA-relationships of families are therefore of particular interest in seeking to understand the role(s) of Mc at the interface of auto-immunity and healthy allo-immunity. This review will begin by providing perspective on Mc in biology followed by a primary focus on persistent Mc according to the human lifespan, in healthy individuals and with illustrative examples of autoimmune diseases.

Indexed as

ChimerismMaternal-Fetal ExchangeAnimalsAutoimmune DiseasesFemaleHLA AntigensHumansPregnancyHLA AntigensAutoimmune diseaseHLAMicrochimerism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.